125 related articles for article (PubMed ID: 1849810)
21. Ageing, serotonin and ketanserin.
Breckenridge A
Drugs; 1988; 36 Suppl 1():44-54. PubMed ID: 3071462
[TBL] [Abstract][Full Text] [Related]
22. Haemodynamic response to ketanserin in rabbits with Page hypertension: comparison with prazosin.
Wright CE; Angus JA
J Hypertens; 1983 Aug; 1(2):183-90. PubMed ID: 6681038
[TBL] [Abstract][Full Text] [Related]
23. Alpha-adrenergic blockade makes minimal contribution to ketanserin's hypotensive effect.
Naslund TC; Merrell WJ; Nadeau JH; Wood AJ
Clin Pharmacol Ther; 1988 Dec; 44(6):699-703. PubMed ID: 2904312
[TBL] [Abstract][Full Text] [Related]
24. Hemodynamic effects of the anti-hypertensive agent ketanserin in hypertension in man.
Weiss YA; Fournier V; Pannier B; Laurent S; Safar ME
Acta Cardiol; 1987; 42(5):329-37. PubMed ID: 3321806
[TBL] [Abstract][Full Text] [Related]
25. Evidence for a 5-HT1-like receptor mediating the amplifying action of 5-HT in the rabbit ear artery.
de la Lande IS
Br J Pharmacol; 1992 Sep; 107(1):550-5. PubMed ID: 1422578
[TBL] [Abstract][Full Text] [Related]
26. Effects of a new serotonin antagonist, ketanserin, in experimental and clinical hypertension.
Hedner T; Persson B
Am J Hypertens; 1988 Jul; 1(3 Pt 3):317S-323S. PubMed ID: 3046635
[TBL] [Abstract][Full Text] [Related]
27. Antihypertensive mechanism of ketanserin in postoperative hypertension after cardiopulmonary bypass.
Anger C; Carter JA; Prys-Roberts C
Anesth Analg; 1988 Feb; 67(2):99-106. PubMed ID: 3277483
[TBL] [Abstract][Full Text] [Related]
28. Characterization of the antihypertensive properties of ketanserin (R 41 468) in rats.
Kalkman HO; Timmermans PB; Van Zwieten PA
J Pharmacol Exp Ther; 1982 Jul; 222(1):227-31. PubMed ID: 6283070
[No Abstract] [Full Text] [Related]
29. Differences in the acute and chronic antihypertensive mechanism of action of ketanserin in spontaneously hypertensive rats.
Balasubramaniam G; Lee HS; Mah SC
J Pharmacol Exp Ther; 1993 Jan; 264(1):129-34. PubMed ID: 8093720
[TBL] [Abstract][Full Text] [Related]
30. Divergent effects of serotonin on coronary-artery dimensions and blood flow in patients with coronary atherosclerosis and control patients.
Golino P; Piscione F; Willerson JT; Cappelli-Bigazzi M; Focaccio A; Villari B; Indolfi C; Russolillo E; Condorelli M; Chiariello M
N Engl J Med; 1991 Mar; 324(10):641-8. PubMed ID: 1994246
[TBL] [Abstract][Full Text] [Related]
31. Does acute serotonergic type-2 antagonism reduce blood pressure? Comparative effects of single doses of ritanserin and ketanserin in essential hypertension.
Hosie J; Stott DJ; Robertson JI; Ball SG
J Cardiovasc Pharmacol; 1987; 10 Suppl 3():S86-8. PubMed ID: 2446081
[TBL] [Abstract][Full Text] [Related]
32. Ketanserin: a possible tool for studying the role of serotonin in hypertension.
Woittiez AJ; Wenting GJ; Man in't Veld AJ; Boomsma F; Schalekamp MA
J Cardiovasc Pharmacol; 1985; 7 Suppl 7():S130-6. PubMed ID: 2412035
[TBL] [Abstract][Full Text] [Related]
33. Serotonin antagonism reduces the adverse symptoms of beta blockade.
Korlipara K; Gould SE; Taylor NA; Chandler A
Cardiovasc Drugs Ther; 1990 Jan; 4 Suppl 1():127-31. PubMed ID: 1981022
[TBL] [Abstract][Full Text] [Related]
34. Kinetic-dynamic relationships and antihypertensive mechanisms of ketanserin in essential hypertension.
Donnelly R; Elliott HL; Meredith PA; Reid JL
J Hypertens Suppl; 1988 Dec; 6(4):S643-5. PubMed ID: 2853763
[TBL] [Abstract][Full Text] [Related]
35. Hemodynamic response to chronic ketanserin treatment in essential hypertension.
Fagard R; Fiocchi R; Lijnen P; Staessen J; Amery A
J Cardiovasc Pharmacol; 1985; 7 Suppl 7():S128-9. PubMed ID: 2412034
[TBL] [Abstract][Full Text] [Related]
36. Ketanserin in essential hypertension. Effects of blood pressure on renal hemodynamics.
Ram CV
Am J Hypertens; 1988 Jul; 1(3 Pt 3):309S-311S. PubMed ID: 3046633
[TBL] [Abstract][Full Text] [Related]
37. Effect of ouabain on the rabbit ear artery contraction to serotonin: enhanced response mediated by serotonergic rather than alpha adrenergic receptors.
Xu Z; Mondal G; Song JP; Purdy RE
J Pharmacol Exp Ther; 1990 May; 253(2):668-75. PubMed ID: 2160006
[TBL] [Abstract][Full Text] [Related]
38. Ketanserin in essential hypertension: use as monotherapy and in combination with a diuretic or beta-adrenoceptor antagonist.
Cameron HA; Waller PC; Ramsay LE
Br J Clin Pharmacol; 1987 Dec; 24(6):705-11. PubMed ID: 2894215
[TBL] [Abstract][Full Text] [Related]
39. Regional haemodynamics and antihypertensive effects during long-term ketanserin treatment.
Persson B; Petterson A; Andersson O; Berglund G; Hedner T
J Hypertens Suppl; 1986 Apr; 4(1):S99-101. PubMed ID: 2939223
[TBL] [Abstract][Full Text] [Related]
40. Serotonin metabolism and age-related effects of antihypertensive therapy with ketanserin.
Amstein R; Fetkovska N; Ferracin F; Pletscher A; Bühler FR
Drugs; 1988; 36 Suppl 1():61-6. PubMed ID: 2467792
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
